Statistics
Publications
9
Citations
2K
H-Index
9
Active since
2004
Affiliations
Novartis (United States)(Current)
Zhouliang Chen is an author at Novartis (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.
Publications per year
2004–2020
9
9
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
Ying-Nan P. Chen, Matthew J. LaMarche, Ho Man Chan et al. · Nature · 2016 · 929 citations
Dual Allosteric Inhibition of SHP2 Phosphatase
Michelle Fodor, Edmund V. Price, Ping Wang et al. · ACS Chemical Biology · 2018 · 130 citations · Full text
Michael D. Shultz, Atwood K. Cheung, C.A. Kirby et al. · Journal of Medicinal Chemistry · 2013 · 123 citations · Full text
1–5 of 9